Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer

N M A White1, T-F F Chow, S Mejia-Guerrero

  • 1Department of Laboratory Medicine, Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.

Abstract

Insights

MicroRNAs (miRNAs) fine-tune kallikrein-related peptidase (KLK) expression in ovarian cancer. Increased miRNA levels reduce KLK protein, inhibiting cell growth, suggesting potential miRNA-based therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Kallikrein-related peptidases (KLKs) are serine proteases implicated in various cancers, including ovarian cancer.
  • Dysregulation of KLK gene expression in cancer is not fully understood.
  • MicroRNAs (miRNAs) are investigated as potential post-transcriptional regulators of KLK expression in malignancy.

Purpose of the Study:

  • To investigate the role of miRNAs in regulating KLK expression in ovarian cancer.
  • To identify specific miRNAs targeting KLK10.
  • To determine the functional impact of miRNA-KLK10 interaction on ovarian cancer cell proliferation.

Main Methods:

  • In silico analysis of miRNA expression in ovarian cancer.
  • Luciferase reporter assays to verify miRNA-KLK10 interaction.
  • Measurement of KLK10 protein and mRNA levels following miRNA transfection.
  • Assessment of cell growth after miRNA transfection.

Main Results:

  • Three miRNAs (let-7f, miR-224, miR-516a) were predicted and experimentally validated to target KLK10.
  • Transfection with these miRNAs decreased KLK10 protein expression and ovarian cancer cell growth in a dose-dependent manner.
  • KLK10 protein levels were partially restored by co-transfection with let-7f inhibitor, and a slight decrease in KLK10 mRNA was observed.

Conclusions:

  • KLKs can be targeted by multiple miRNAs, indicating a complex regulatory network.
  • Increased expression of specific miRNAs in ovarian cancer can suppress KLK protein levels and inhibit cell proliferation.
  • These findings highlight the potential of miRNAs as therapeutic targets for ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...